Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Elements in the 5' Untranslated Region of Viral RNA Important for HIV Gag Recognition and Cross-Packaging
  2. Cheng,Zetao; Nikolaitchik,Olga; Duchon,Alice; Rawson, Jonathan M O; Pathak,Vinay; Hu,Wei-Shau
  3. Viruses. 2025, Apr 10; 17(4): 551.
  1. 2.   Adaptation of HIV-1/HIV-2 Chimeras with Defects in Genome Packaging and Viral Replication
  2. Rawson, Jonathan M O; Nikolaitchik,Olga; Yoo, Jennifer A; Somoulay, Xayathed; Brown, Matthew A; Mbuntcha Bogni, Franck S; Pathak,Vinay; Soheilian,Ferri; Slack, Ryan L; Sarafianos, Stefan G; Hu,Wei-Shau
  3. mBio. 2022, Aug 29; e0222022.
  1. 3.   The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections
  2. Bender, Alexandra M; Simonetti, Francesco R; Kumar, Mithra R; Fray, Emily J; Bruner, Katherine M; Timmons, Andrew E; Tai, Katherine Y; Jenike, Katharine M; Antar, Annukka A R; Liu, Po-Ting; Ho, Ya-Chi; Raugi, Dana N; Seydi, Moussa; Gottlieb, Geoffrey S; Okoye, Afam A; Del Prete,Greg; Picker, Louis J; Mankowski, Joseph L; Lifson,Jeffrey; Siliciano, Janet D; Laird, Greg M; Barouch, Dan H; Clements, Janice E; Siliciano, Robert F
  3. Cell host & microbe. 2019, Jul 10; 26(1): 73-85.e4.
  1. 4.   HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants
  2. Smith, J. L.; Izumi, T.; Borbet, T. C.; Hagedorn, A. N.; Pathak, V. K.
  3. Journal of Virology. 2014, 1-Sep; 88(17): 9893-908.
  1. 5.   [Analysis of genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2]
  2. Motomura, K.
  3. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 2009 83(2): 81-93.
  1. 6.   Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by Rous sarcoma virus RNase H but do cause aberrant integrations in vivo
  2. Oh, J.; Chang, K. W.; Hughes, S. H.
  3. Journal of Virology. 2006, JAN; 80(1): 451-459.
  1. 7.   Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones
  2. Budihas, S. R.; Gorshkova, I.; Gaidamakov, S.; Wamiru, A.; Bona, M. K.; Parniak, M. A.; Crouch, R. J.; McMahon, J. B.; Beutler, J. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2005 33(4): 1249-1256.
  1. 8.   AZT resistance: why do HIV-1 and HIV-2 choose different pathways?
  2. Boyer, P. L.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Antiviral Therapy. 2005 10(4): S92-S92.
  1. 9.   Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes
  2. Voronin, Y. A.; Pathak, V. K.
  3. Journal of Virology. 2004 78(10): 5402-5413.
  1. 10.   A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
  2. Xu, H. Z.; Svarovskaia, E. S.; Barr, R.; Zhang, Y. J.; Khan, M. A.; Strebel, K.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(15): 5652-5657.
  1. 11.   The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits
  2. Sevilya, Z.; Loya, S.; Hughes, S. H.; Hizi, A.
  3. Journal of Molecular Biology. 2001 311(5): 957-971.
  1. 12.   Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques
  2. Patterson, L. J.; Peng, B.; Abimiku, A. G.; Aldrich, K.; Murty, L.; Markham, P. D.; Kalyanaraman, V. S.; Alvord, W. G.; Tartaglia, J.; Franchini, G.; Robert-Guroff, M.
  3. Aids. 2000 14(16): 2445-2455.
  1. 13.   Varying effects of temperature, Ca2+ and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins
  2. Jernigan, K. M.; Blumenthal, R.; Puri, A.
  3. Febs Letters. 2000 474(2-3): 246-251.
  1. 14.   Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates
  2. Tozser, J.; Bagossi, P.; Boross, P.; Louis, J. M.; Majerova, E.; Oroszlan, S.; Copeland, T. D.
  3. European Journal of Biochemistry. 1999 265(1): 423-429.
  1. 15.   HIV replication persists in patients receiving HAART despite undetectable plasma virus
  2. Nata Rajan, V. N.; Chun, T. W.; O'Neill, D. P.; Metcalf, J. A.; Mican, J.; Engel, D.; Fauci, A. S.; Lane, H. C.; Kovacs, J. A.
  3. International Conference on AIDS. 1998, 12 341-2.
  1. 16.   Identification of a novel bisimidazoacridone that inhibits HIV-1 replication by prevention of formation of post-integrative full-length RNA transcripts
  2. Turpin, J. A.; Williamson, K.; Schaeffer, C. A.; Bu, M.; Cholody, W. M.; Michejda, C. J.; Rice, W. G.
  3. Conference on Retroviruses and Opportunistic Infections. 1997, 106 (abstract no. 226).
  1. 17.   Analysis of Hiv-2 Rt Mutants Provides Evidence That Resistance of Hiv-1 Rt and Hiv-2 Rt to Nucleoside Analogs Involves a Repositioning of the Template-Primer
  2. Perach, M.; Rubinek, T.; Hughes, S. H.; Hizi, A.
  3. Journal of Molecular Biology. 1997 268(3): 648-654.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel